학술논문
Nanobodies with cross-neutralizing activity provide prominent therapeutic efficacy in mild and severe COVID-19 rodent models
Document Type
Article
Author
Source
In Virologica Sinica October 2023 38(5):787-800
Subject
Language
ISSN
1995-820X